Naturally Occurring Mutations in Glycoprotein Ibα That Result in Defective Ligand Binding and Synthesis of a Truncated Protein
Open Access
- 1 July 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (1) , 175-183
- https://doi.org/10.1182/blood.v92.1.175.413a36_175_183
Abstract
The platelet GPIb-V-IX complex is the receptor for the initial binding of von Willebrand factor (vWF) mediating platelet adhesion. The complex is composed of four membrane-spanning glycoproteins (GP): GPIbα, GPIbβ, GPIX, and GPV. Bernard-Soulier syndrome results from a qualitative or quantitative defect in one or more components of the platelet membrane GPIb-V-IX complex. We describe the molecular basis of a novel Bernard-Soulier syndrome variant in two siblings in whom GPIbα was not detected on the platelet surface but that was present in a soluble form in plasma. DNA sequence analysis showed that the affected individuals were compound heterozygotes for two mutations. One, inherited from a maternal allele, a T777 → C point mutation in GPIbα converting Cys65 → Arg within the second leucine rich repeat, the other, a single nucleotide substitution (G2078 → A) for the tryptophan codon (TGG) causing a nonsense codon (TGA) at residue 498 within the transmembrane region of GPIbα, inherited from a mutant paternal allele. The Bernard-Soulier phenotype was observed in siblings who were compound heterozygotes for these two mutations. Although GPIbα was not detected on the surface of the patient's platelets, soluble GPIbα could be immunoprecipitated from plasma. When plasmids encoding GPIbα containing the Cys65 → Arg mutation were transiently transfected into Chinese hamster ovary (CHO) cells stably expressing the GPβ-IX complex (CHOβIX), the expression of GPIbα was similar to the wild-type (WT) GPIbα, but did not bind vWF. When plasmids encoding GPIbα containing the Trp498 → stop were transiently transfected into CHOβIX, the surface expression of GPIbα was barely detectable compared with the WT GPIbα. Thus, this newly described compound heterozygous defect produces Bernard-Soulier syndrome by a combination of synthesis of a nonfunctional protein and of a truncated protein that fails to insert into the platelet membrane and is found circulating in plasma.Keywords
This publication has 54 references indexed in Scilit:
- Bernard-Soulier Syndrome with Severe Bleeding: Absent Platelet Glycoprotein lb alpha Due to a Homozygous One-base DeletionThrombosis and Haemostasis, 1996
- Expression of Platelet Glycoprotein (GP) V in Heterologous Cells and Evidence for Its Association with GP Ibα in Forming a GP Ib-IX-V Complex on the Cell SurfacePublished by Elsevier ,1995
- The leucine-rich repeat: a versatile binding motifTrends in Biochemical Sciences, 1994
- The platelet glycoprotein Ib???IX complexBlood Coagulation & Fibrinolysis, 1994
- Glycocalicin: a new assay--the normal plasma levels and its potential usefulness in selected diseasesBlood, 1994
- Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteinsBlood, 1991
- The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.Proceedings of the National Academy of Sciences, 1988
- Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein.Proceedings of the National Academy of Sciences, 1987
- Evidence that glycocalicin circulates in normal plasma.Journal of Clinical Investigation, 1984
- Platelets have more than one binding site for von Willebrand factor.Journal of Clinical Investigation, 1983